1. Home
  2. Labeler Index
  3. Northwind Pharmaceuticals
  4. 51655-698
  5. Product Images: Valsartan And Hydrochlorothiazide

Product Images Valsartan And Hydrochlorothiazide

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 7 images provide visual information about the product associated with Valsartan And Hydrochlorothiazide NDC 51655-698 by Northwind Pharmaceuticals, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Label - 51655 698 52 Master Bottle Label Approval Rev A 03 21

Label - 51655 698 52 Master Bottle Label Approval Rev A 03 21

NDC: 51655-698-52 Valsartan and Hydrochlorothiazide Tablets, USP 160mg/12.5mg, 30 Tablets, Rx Only. The package insert contains dosage information and storage instructions. Store at 2-25°C (68-77°F) with excursions permitted to 15°-30°C (59°-86°F). The medication should be kept out of the reach of children and stored in the original container to protect from moisture. The tablet is film-coated and contains 160mg of Valsartan and 12.5mg of Hydrochlorothiazide. This medication has been repackaged by Northwind Pharmaceuticals with serial number 000000000000000. The lot number is 0000000000 with an expiration date of 00/00/0000. The manufacturer is Macleods Pharma USA, Inc. This information is useful for those considering using or dispensing this medication.*

figure-1 - valsartan hctz figure 1

figure-1 - valsartan hctz figure 1

This text is describing a table showing the baseline systolic blood pressure (SBP) levels in mmHg for a study involving different medications for hypertension. The medications listed are Valsartan HCT 320/25mg, Amlodipine/Valsartan 10/320mg, Valsartan 320mg, Hydrochlorothiazide 25mg, and Placebo. The table also includes readings of SBP ranges from 140 to 180 mmHg.*

figure-2 - valsartan hctz figure 2

figure-2 - valsartan hctz figure 2

This appears to be a table showing the results of a study evaluating blood pressure medication. The medications tested were valsartan HCT 320/25 mg, AAA valsartan 320 mg, hydrochlorothiazide 25 mg, and a placebo. The data presented shows the baseline diastolic blood pressure (DBP) at 105 mmHg, and the goal was to reduce it to below 90 mmHg. However, without more information, it is difficult to provide a more detailed description of the study and its outcomes.*

figure-3 - valsartan hctz figure 3

figure-3 - valsartan hctz figure 3

figure-4 - valsartan hctz figure 4

figure-4 - valsartan hctz figure 4

This is a chart showing the baseline diastolic blood pressure (DBP in mmHg) readings for patients taking Valsartan HCT 320/125 mg or Valsartan 320 mg along with Hydrochlorothiazide 25 mg versus a placebo. The readings range from 95 mmHg to 105 mmHg.*

hctz-stru - valsartan hctz hydrochlorothiazide

hctz-stru - valsartan hctz hydrochlorothiazide

valsartan-str - valsartan hctz valsartan

valsartan-str - valsartan hctz valsartan

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.